About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Amsterdam Rheumatology and Immunology Center
›
Top Articles
Amsterdam Rheumatology and Immunology Center
26
(top 2%)
papers
558
(top 2%)
citations
12
(top 2%)
h
-index
24
(top 2%)
g
-index
33
all documents
678
doc citations
359
citing journals
40
times ranked
Top Articles
#
Title
Journal
Year
Citations
1
COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study
BMC Medical Research Methodology
2020
205
2
The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis
Drug Delivery and Translational Research
2019
78
3
Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide
Drugs and Aging
2019
61
4
Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting*
British Journal of Dermatology
2021
52
5
Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention
Expert Opinion on Pharmacotherapy
2020
47
6
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis
Drugs
2019
37
7
An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis
Expert Opinion on Drug Safety
2019
30
8
Outcome measures for adherence data from a medication event monitoring system: A literature review
Journal of Clinical Pharmacy and Therapeutics
2019
27
9
An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults
Ocular Immunology and Inflammation
2021
26
10
Management of glucocorticoid-induced osteoporosis
Aging Clinical and Experimental Research
2021
20
11
High-intensity versus low-intensity resistance training in patients with knee osteoarthritis: A randomized controlled trial
Clinical Rehabilitation
2022
16
12
Patients’ and rheumatologists’ perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis—an international survey within the GLORIA study
Rheumatology
2021
13
13
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
Lancet Rheumatology, The
2022
12
14
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio
Rheumatology and Therapy
2020
11
15
Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis
Frontiers in Immunology
2019
9
16
Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells
Cells
2021
8
17
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
Frontiers in Immunology
2021
7
18
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma
OncoImmunology
2020
5
19
The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence
Current Opinion in Rheumatology
2022
4
20
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group
Annals of the Rheumatic Diseases
2020
3
21
The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
Clinical Rheumatology
2022
2
22
Favorable effect of a ‘second hit’ after 13 weeks in early RA non-responders: The Amsterdam COBRA treat-to-target randomized trial
Rheumatology
0
2
23
ACPA epitopes — what are we actually looking at?
Nature Reviews Rheumatology
2019
1
24
Authors’ Reply to Comment on “Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide”
Drugs and Aging
2020
1
25
Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial
Trials
2021
1
26
P70 Increased work loss during pregnancy in women with systemic lupus erythematosus compared to matched healthy controls
Trials
2020
0
27
Work participation and sick leave in women with systemic lupus erythematosus and matched controls during and after pregnancy
Clinical and Experimental Rheumatology
2020
0
28
AB0166 PROTOCOL VIOLATIONS IN AN OPEN, RANDOMIZED, TRIAL IN EARLY RA PATIENTS: POTENTIAL IMPACT OF SHARED DECISION MAKING
Annals of the Rheumatic Diseases
2022
0
29
Association Between Measures of Muscle Strength and Performance of Daily Activities in Patients with Knee Osteoarthritis
Journal of Rehabilitation Medicine
0
0
30
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids
Rheumatology
0
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.